CARLA PHAM: Open Payments
NPI 1740711084 · UNIONTOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,463 in 132 payments from 12 companies in 2025. Trend: 2023 $2,476 · 2024 $10,423 · 2025 $7,463
Consulting: $3,780Food & beverage: $3,045Travel & lodging: $637
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 14 | $4,990 |
| EMD Serono, Inc. | 25 | $656 |
| Genentech USA, Inc. | 27 | $557 |
| Biogen, Inc. | 17 | $507 |
| Novartis Pharmaceuticals Corporation | 23 | $221 |
| Celgene Corporation | 14 | $159 |
| TG Therapeutics, Inc. | 1 | $124 |
| Cycle Pharmaceuticals Inc | 5 | $89 |
| Vanda Pharmaceuticals Inc. | 2 | $57 |
| Genentech, Inc. | 2 | $53 |
Products named: Ocrevus Zunovo, TYSABRI, KESIMPTA, ZEPOSIA, BRIUMVI, VUMERITY, Enspryng, Ocrevus.
Industry payments across OH — which companies pay providers there.
